Literature DB >> 8303629

Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis.

A Itoh1, E Yamaguchi, K Furuya, N Hizawa, N Ohnuma, Y Kawakami, N Kuzumaki.   

Abstract

BACKGROUND: Granulocyte-macrophage colony stimulating factor (GM-CSF) has several proinflammatory effects, some of which potentially favour granuloma formation. Its mRNA expression by the inflammatory cells recovered from lungs of patients with pulmonary sarcoidosis has been previously reported. In this study an association between GM-CSF expression and manifestations of the disease was explored.
METHODS: GM-CSF mRNA was detected by reverse transcription polymerase chain reaction in the cells of bronchoalveolar lavage (BAL) fluid of 20 patients with pulmonary sarcoidosis.
RESULTS: GM-CSF mRNA expression was positive in 15 of 20 patients with sarcoidosis. Fourteen of the 15 patients with positive mRNA expression had worsening or unchanged disease during the year preceding this study, on the basis of radiographic or physical findings, or both, whereas all five "negative" patients were judged to be improving. Similarly, serum levels of angiotensin converting enzyme, the proportion of lymphocytes in BAL fluid, and the CD4+/CD8+ ratio of lymphocytes in BAL fluid were significantly higher in the positive patients.
CONCLUSIONS: There was an association between the presence of GM-CSF mRNA in the cells in BAL fluid and other indices of disease activity in sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8303629      PMCID: PMC464979          DOI: 10.1136/thx.48.12.1230

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

1.  Enhanced expression of CD2 antigen on lung T cells.

Authors:  E Yamaguchi; N Okazaki; A Itoh; K Furuya; S Abe; Y Kawakami
Journal:  Am Rev Respir Dis       Date:  1991-04

Review 2.  T lymphocyte-derived colony-stimulating factors.

Authors:  A Kelso; D Metcalf
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

Review 3.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

4.  Expression of granulocyte-macrophage colony-stimulating factor mRNA by inflammatory cells in the sarcoid lung.

Authors:  A Itoh; E Yamaguchi; N Kuzumaki; N Okazaki; K Furuya; S Abe; Y Kawakami
Journal:  Am J Respir Cell Mol Biol       Date:  1990-09       Impact factor: 6.914

5.  Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis.

Authors:  H Kreipe; H J Radzun; K Heidorn; J Barth; J Kiemle-Kallee; W Petermann; J Gerdes; M R Parwaresch
Journal:  Lab Invest       Date:  1990-06       Impact factor: 5.662

6.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

7.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.

Authors:  P Pinkston; P B Bitterman; R G Crystal
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

8.  Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis.

Authors:  R A DeRemee; M S Rohrbach
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

9.  Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro.

Authors:  K Nakata; K S Akagawa; M Fukayama; Y Hayashi; M Kadokura; T Tokunaga
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

10.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

View more
  1 in total

1.  Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.

Authors:  Toru Arai; Takahiko Kasai; Kazunori Shimizu; Kunimitsu Kawahara; Kanako Katayama; Chikatoshi Sugimoto; Masaki Hirose; Hiroyuki Okamoto; Kazunobu Tachibana; Masanori Akira; Yoshikazu Inoue
Journal:  Intern Med       Date:  2020-06-30       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.